Action Point Financial Planning’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,926
Closed -$8.01K – 1483
2026
Q2
$8.01K Buy
+1,926
New +$7.32K ﹤0.01% 1566

Other funds holding IOVA

Action Point Financial Planning's IOVA Position: Q3 2026 in Review

Action Point Financial Planning sold out of Iovance Biotherapeutics (IOVA) in Q3 2026, closing a stake of 1,926 shares — an estimated $8.01K sold.

Action Point Financial Planning first reported a position in IOVA in Q2 2026 and held it in 1 quarter. The position peaked at $8.01K in Q2 2026. 335 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.

  • Action Point Financial Planning reported no remaining Iovance Biotherapeutics position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 1,926 Iovance Biotherapeutics shares in Q3 2026, an estimated $8.01K.
  • Action Point Financial Planning first reported a position in Iovance Biotherapeutics in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's Iovance Biotherapeutics position peaked at $8.01K in Q2 2026.
  • 335 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.